Stormy Chamberlain is associate professor of genetics and genome sciences and associate director of the Graduate Program in Genetics and Developmental Biology at the University of Connecticut School of Medicine.
Stormy Chamberlain
Associate professor
University of Connecticut
From this contributor
Angelman syndrome’s silent gene points way forward for autism therapies
Advances in research and help from families have brought scientists to the brink of an effective therapy for Angelman syndrome.
Angelman syndrome’s silent gene points way forward for autism therapies
For accurate results in autism, genetic databases need diversity
We must diversify databases of reference DNA to improve our ability to interpret the consequences of genetic variation.
For accurate results in autism, genetic databases need diversity
Explore more from The Transmitter
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.